<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>1631373</identifier>
<setSpec>0014-2565</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Zancada Díaz de Entre-Sotos, F</dc:author>
<dc:author>Agulla Budiño, A</dc:author>
<dc:author>Jiménez Jiménez, F J</dc:author>
<dc:author>Fernández Ballesteros, A</dc:author>
<dc:author>Roldán Montaud, A</dc:author>
<dc:description xml:lang="en">UNLABELLED We analyze retrospectively 132 cases of brucellosis evaluating the performance of diagnostic procedures, complications and serological and clinical evolution. We compare the 74 patients treated with streptomycin plus tetracycline versus the 41 patients treated with doxycycline plus rifampicin. The more outstanding results we find: a) Great sensibility of the rose bengal test; b) Higher relapse rate in the more severe cases (p less than 0.01); c) Good evolution with scarce relapse rate in both treatment groups; agglutination titers were lower at one year in the group treated with doxycycline plus rifampicin (p less than 0.05). CONCLUSIONS Both treatments showed good efficacy, controlled studies would be needed to determine the most adequate one.</dc:description>
<dc:type>Comparative Study</dc:type>
<dc:language>es</dc:language>
<dc:date>1992 Jun </dc:date>
<dc:title xml:lang="es">Brucelosis: estudio clinicoserológico en un área de salud rural.</dc:title>
<dc:title xml:lang="en">[Brucellosis: a clinico-serological study in a rural health area].</dc:title>
<dc:publisher>Revista clinica espanola</dc:publisher>
</metadata>
</record>
</pubmed-document>
